In parallel, in MCF-7 breast cancer cells, exposure to the selective ER modulator tamoxifen has been found to induce Src-mediated phosphorylation of p130Cas/BCAR1, which in turn promotes the activation of a pro-survival signalling pathway involving FAK and Akt [31] (Figure 3A). Here, SRC is linked to breast carcinoma.